These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 17112857)

  • 1. Influence of methylprednisolone on plasma homocysteine levels in cadaveric renal transplant recipients.
    Libetta C; Sepe V; Zucchi M; Pisacco P; Portalupi V; Adamo G; Soccio G; Dal Canton A
    Transplant Proc; 2006 Nov; 38(9):2893-4. PubMed ID: 17112857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma homocysteine levels in renal transplant patients on tacrolimus therapy.
    Akbas SH; Tuncer M; Gurkan A; Yucetin L; Yavuz A; Demirbas A; Ersoy F; Gultekin M; Yakupoglu G; Akaydin M
    Transplant Proc; 2004; 36(1):159-60. PubMed ID: 15013332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine.
    Gonzalez Molina M; Morales JM; Marcen R; Campistol JM; Oppenheimer F; Serón D; Gil-Vernet S; Capdevila L; Andrés A; Lampreave I; Del Castillo D; Cabello M; Burgos D; Valdés F; Anaya F; Escuín F; Arias M; Pallardó L; Bustamante J
    Transplant Proc; 2007 Sep; 39(7):2167-9. PubMed ID: 17889126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy.
    Sartori MT; Rigotti P; Marchini F; Spiezia L; Baldan N; Furian L; Varvarikis C; Girolami A
    Transplantation; 2003 Apr; 75(7):994-8. PubMed ID: 12698086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
    Falkiewicz K; Kamińska D; Nahaczewska W; Boratyńska M; Owczarek H; Klinger M; Woźniak M; Patrzałek D; Szyber P
    Transplant Proc; 2006; 38(1):119-22. PubMed ID: 16504680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of fasting total serum homocysteine levels in liver transplant recipients.
    Akoglu B; Wondra K; Caspary WF; Faust D
    Exp Clin Transplant; 2006 Jun; 4(1):462-6. PubMed ID: 16827644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney transplantation with corticosteroid-free maintenance immunosuppression: a single center analysis of graft and patient survivals.
    Filipe R; Mota A; Alves R; Bastos C; Macário F; Figueiredo A; Roseiro A; Parada B; Sá H; Nunes P; Bastos M
    Transplant Proc; 2009 Apr; 41(3):843-5. PubMed ID: 19376367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
    Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
    Walker JK; Alloway RR; Roy-Chaudhury P; Mogilishetty G; Cardi MA; Weimert NA; Rike AH; First MR; Woodle ES
    Transplantation; 2009 Feb; 87(3):408-14. PubMed ID: 19202447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of steroid-free protocols in primary cadaver kidney transplantation.
    Nghiem DD; Carpenter BJ; Schlosser JD; Sureshkumar K; Vivas CA; Frowen SE; Marcus RJ
    Transplant Proc; 2005 May; 37(4):1797-9. PubMed ID: 15919470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
    Yu X; Zhang B; Xing C; Sun B; Liu M; Zhang W; Gu M
    Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on post-transplant dyslipidemia in kidney transplant patients.
    Marubayashi S; Ohdan H; Tashiro H; Tokita D; Onoe T; Hayamizu K; Asahara T; Doi S; Okumoto S; Tanji C; Kawai T; Taniguchi Y; Fukuda Y; Dohi K
    Hiroshima J Med Sci; 2005 Jun; 54(2):39-45. PubMed ID: 15991596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic evaluation of short-term outcome after early corticosteroid discontinuation in kidney transplantation.
    Miura M; Ogawa Y; Kubota KC; Harada H; Shimoda N; Seki T; Hirano T; Nonomura K
    Clin Transplant; 2009 Aug; 23 Suppl 20():10-6. PubMed ID: 19594589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in kidney transplant patients.
    Campise M; Bamonti F; Novembrino C; Ippolito S; Tarantino A; Cornelli U; Lonati S; Cesana BM; Ponticelli C
    Transplantation; 2003 Nov; 76(10):1474-8. PubMed ID: 14657689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased asymmetric dimethylarginine serum levels are associated with acute rejection in kidney transplant recipients.
    Esposito C; Grosjean F; Torreggiani M; Maggi N; Esposito V; Migotto C; Mangione F; Tinelli C; Dal Canton A
    Transplant Proc; 2009 Jun; 41(5):1570-3. PubMed ID: 19545681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative status in stable renal transplantation.
    Minz M; Heer M; Arora S; Sharma A; Khullar M
    Transplant Proc; 2006 Sep; 38(7):2020-1. PubMed ID: 16979986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.